143665-38-7

Upstream product

• 80866-88-2 (3-methoxy-4-nitrophenyl)methanol 
• 80410-57-7 3-methoxy-4-nitrobenzaldehyde 
• 1099-45-2 ethyl (triphenylphosphoranylidene)acetate 

Downstream Products

• 1407520-55-1 C₂₆H₃₄ClN₆O₄P 
• 1407520-54-0 C₂₆H₃₂ClN₆O₅P 
• 1407520-53-9 C₂₂H₂₃ClN₅O₆P 
• 1407520-52-8 C₂₄H₂₇ClN₅O₆P 
• 1407520-51-7 C₁₂H₁₆N₂O₅ 
• 791774-31-7 ethyl 3-(4-amino-3-methoxyphenyl)propanoate 

Relevant academic research and scientific papers

COMPOUNDS FOR INHIBITING CELL PROLIFERATION IN EGFR-DRIVEN CANCERS

The invention features compounds, pharmaceutical compositions and methods for treating patients who have an EGFR-driven cancer of Formula (I), wherein the variables are as defined herein.

COMPOUNDS FOR INHIBITING CELL PROLIFERATION IN EGFR-DRIVEN CANCERS

The invention features compounds, pharmaceutical compositions and methods for treating patients who have an EGFR-driven cancer of formula (I), wherein the variables are as defined herein.

PPAR AGONIST COMPOUNDS, PREPARATION AND USES

The present invention relates to novel PPAR agonist compounds as well as pharmaceutical compositions containing them. The compounds according to the invention are of quite particular therapeutic interest, notably for treating diabetes and/or dyslipidemias, as well as for preventing cardiovascular pathologies.